HCPCS Level IIdrugActive
J9355
Inj trastuzumab excl biosimi
BETOS: O1E
Effective: 2019-07-01
Referenced in 1 policies
Description
Injection, trastuzumab, excludes biosimilar, 10 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Herceptin
Manufacturer
Genentech, Inc.
HCPCS Dosage
10 MG
Billing Units
15.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.